CIITA and neoplasm: Interestingly, the Ad‐CIITA mutant also led to robust tumor cell killing in the presence of PBMCs (78.3% ± 21.7) (Fig. 4B, Video S1), despite the lack of MHC‐II expression (Fig. 3C).